Tech Company Financing Transactions

Astute Medical Funding Round

Astute Medical secured a $26.5 million Series B investment round on 5/11/2010. Backers included Delphi Ventures, Domain Associates and De Novo Ventures.

Transaction Overview

Company Name
Astute Medical
Announced On
5/11/2010
Transaction Type
Venture Equity
Amount
$26,500,000
Round
Series B
Investors

Delphi Ventures (Lead Investor)

Domain Associates (Lead Investor) (James Blair)

De Novo Ventures (Fred Dotzler)

Johnson & Johnson Development Corporation

Moore Venture Partners (Terry Moore)

Proceeds Purpose
Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3550 General Atomics Ct. Building 02/620
San Diego, CA 92121
USA
Phone
(858) 500-7000
Website
www.astutemedical.com
Email Address
[email protected]
Overview
Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers.
Profile
Astute Medical LinkedIn Company Profile
Social Media
Astute Medical Company Twitter Account
Company News
Astute Medical News
Facebook
Astute Medical on Facebook
YouTube
Astute Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chris Hibberd
  Chris Hibberd LinkedIn Profile  Chris Hibberd Twitter Account  Chris Hibberd News  Chris Hibberd on Facebook
Chief Financial Officer
Todd Myers
  Todd Myers LinkedIn Profile  Todd Myers Twitter Account  Todd Myers News  Todd Myers on Facebook
Chief Scientific Officer
Paul McPherson
  Paul McPherson LinkedIn Profile  Paul McPherson Twitter Account  Paul McPherson News  Paul McPherson on Facebook
VP - Engineering
Joe Anderberg
  Joe Anderberg LinkedIn Profile  Joe Anderberg Twitter Account  Joe Anderberg News  Joe Anderberg on Facebook
VP - Product Management
Ravi Vijayendran
  Ravi Vijayendran LinkedIn Profile  Ravi Vijayendran Twitter Account  Ravi Vijayendran News  Ravi Vijayendran on Facebook
VP - Regulatory Affairs
Karin Hughes
  Karin Hughes LinkedIn Profile  Karin Hughes Twitter Account  Karin Hughes News  Karin Hughes on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/11/2010: Vantrix venture capital transaction
Next: 5/11/2010: Wiggio venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.